Skip to Content

Perrigo Co PLC PRGO

Morningstar Rating
$26.41 −0.89 (3.26%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Price vs Fair Value

PRGO is trading at a 29% discount.
Price
$26.41
Fair Value
$82.00
Uncertainty
Medium
1-Star Price
$91.81
5-Star Price
$37.60
Economic Moat
Bbpq
Capital Allocation
Hwwmnwg

Bulls Say, Bears Say

Bulls

Perrigo is now more tapped in to the higher-margin branded consumer health market, and this should act as tailwind to the top and bottom lines in future.

Bears

By expanding its business to focus more on branded products, Perrigo now faces stiffer competition from larger consumer healthcare product manufacturers.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PRGO is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$27.30
Day Range
$26.2127.66
52-Week Range
$26.2140.28
Bid/Ask
$26.39 / $26.41
Market Cap
$3.58 Bil
Volume/Avg
1,799 / 1.9 Mil

Key Statistics

Price/Earnings (Normalized)
10.24
Price/Sales
0.77
Dividend Yield (Trailing)
4.13%
Dividend Yield (Forward)
4.13%
Total Yield
4.13%

Company Profile

Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm’s product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
8,900

Competitors

Valuation

Metric
PRGO
KVUE
HLN
Price/Earnings (Normalized)
10.2414.3619.00
Price/Book Value
0.753.361.79
Price/Sales
0.772.292.48
Price/Cash Flow
7.7015.0618.00
Price/Earnings
PRGO
KVUE
HLN

Financial Strength

Metric
PRGO
KVUE
HLN
Quick Ratio
0.940.730.54
Current Ratio
1.791.140.84
Interest Coverage
0.954.534.10
Quick Ratio
PRGO
KVUE
HLN

Profitability

Metric
PRGO
KVUE
HLN
Return on Assets (Normalized)
3.23%3.94%3.88%
Return on Equity (Normalized)
7.32%7.85%7.41%
Return on Invested Capital (Normalized)
5.60%6.81%5.99%
Return on Assets
PRGO
KVUE
HLN
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AGgwr$91.5 Bil
MKKGY
Merck KGaA ADRGcnzfnl$74.9 Bil
HLN
Haleon PLC ADRZmr$36.8 Bil
VTRS
Viatris IncRdqt$14.7 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRSlxkj$14.7 Bil
RDY
Dr Reddy's Laboratories Ltd ADRTfqz$12.9 Bil
CTLT
Catalent IncPhxzfy$10.5 Bil
CURLF
Curaleaf Holdings IncNdwqc$3.6 Bil
PBH
Prestige Consumer Healthcare IncTvtgt$3.5 Bil

Sponsor Center